Scholars@Duke
Journal cover image

Patient safety in trials of therapy for acute ischemic stroke.

Publication ,  Journal Article
Goldstein, LB; Albers, GW
Published in: JAMA
February 27, 2002
Published version (DOI) Link to item

Duke Scholars

Larry Bruce Goldstein
Author Larry Bruce Goldstein Neurology, Stroke and Vascular Neurology

Published In

JAMA

DOI

10.1001/jama.287.8.987

ISSN

0098-7484

Publication Date

February 27, 2002

Volume

287

Issue

8

Start / End Page

987

Location

United States

Related Subject Headings

  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Stroke
  • Safety
  • Neuroprotective Agents
  • Humans
  • Guanidines
  • General & Internal Medicine
  • Clinical Trials as Topic
  • Brain Ischemia
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Goldstein, L. B., & Albers, G. W. (2002). Patient safety in trials of therapy for acute ischemic stroke. JAMA, 287(8), 987. https://doi.org/10.1001/jama.287.8.987
Goldstein, Larry B., and Gregory W. Albers. “Patient safety in trials of therapy for acute ischemic stroke.” JAMA 287, no. 8 (February 27, 2002): 987. https://doi.org/10.1001/jama.287.8.987.
Goldstein LB, Albers GW. Patient safety in trials of therapy for acute ischemic stroke. JAMA. 2002 Feb 27;287(8):987.
Goldstein, Larry B., and Gregory W. Albers. “Patient safety in trials of therapy for acute ischemic stroke.” JAMA, vol. 287, no. 8, Feb. 2002, p. 987. Pubmed, doi:10.1001/jama.287.8.987.
Goldstein LB, Albers GW. Patient safety in trials of therapy for acute ischemic stroke. JAMA. 2002 Feb 27;287(8):987.
Journal cover image

Published In

JAMA

DOI

10.1001/jama.287.8.987

ISSN

0098-7484

Publication Date

February 27, 2002

Volume

287

Issue

8

Start / End Page

987

Location

United States

Related Subject Headings

  • Tissue Plasminogen Activator
  • Thrombolytic Therapy
  • Stroke
  • Safety
  • Neuroprotective Agents
  • Humans
  • Guanidines
  • General & Internal Medicine
  • Clinical Trials as Topic
  • Brain Ischemia